VSTM’s PR for its first Investor Day presentation since going public:
Well, they're off to a great start: burying the demise of their lead program towards the bottom of the PR. And a focus now of in-licensing castoffs from big pharma. I have no interest at all in this company.
Market Data 
Markets 
AI
